Clinical trial
A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart…
NCT00487799 · Facet Biotech, Industry · Withdrawn
Key facts
| NCT number | NCT00487799 |
|---|---|
| Title | A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure |
| Official title | A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure |
| Lead sponsor | Facet Biotech, Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | Ularitide |
| Enrollment | 32 |
| First posted | Jun 19, 2007 |
| Last update posted | Jul 20, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: